AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 10,922
-28 (-0.26%)
Aug 8, 2025, 5:31 PM BST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 169.37 billion as of August 8, 2025. Its market cap has decreased by -10.47% in one year.
Market Cap
169.37B
Enterprise Value
188.29B
Revenue
41.24B
Ranking
n/a
PE Ratio
28.19
Stock Price
10,922.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 169.37B, an increase of 3,621.99%. That is a compound annual growth rate of 11.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 169.37B | 4.36% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | 96.14B | -3.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 56.29B |
| Haleon | 31.89B |
| Smith & Nephew | 11.72B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.85B |
| Oxford Nanopore Technologies | 2.07B |
| HUTCHMED (China) | 1.93B |
| Genus | 1.66B |